Rupesh Kotecha, M.D. is a board-certified radiation oncologist and a nationally recognized leader in the field of radiosurgery. He serves as the Chief of Radiosurgery, Director of Research in Radiation Oncology, and Director of the Central Nervous System (CNS) Metastasis Program at Miami Cancer Institute, where he spearheads advancements in cutting-edge cancer treatment. Dr. Kotecha holds academic appointments as a Professor in the Department of Oncological Sciences at the FIU Herbert Wertheim College of Medicine, and as Adjunct Faculty in the Department of Radiation Oncology at Memorial Sloan Kettering Cancer Center—further testament to his national academic impact.
With specialized training in the most advanced radiation therapy techniques, Dr. Kotecha brings extensive expertise in treating both cancerous and noncancerous conditions. His clinical focus centers on stereotactic radiotherapy, utilizing platforms such as CyberKnife, LINAC-based systems, ZAP-X, and GammaKnife radiosurgery. He also excels in re-irradiation, proton beam therapy, and MR-guided radiation therapy—offering precision-targeted care tailored to each patient.
A distinguished scholar, Dr. Kotecha was inducted into the prestigious Alpha Omega Alpha Honor Medical Society during medical school, recognizing his excellence in both academic performance and the practice of medicine. He is a prolific contributor to the scientific community, having delivered over 200 oral and poster presentations, been invited to speak at more than 200 national and international conferences, and authored over 200 publications, including book chapters and peer-reviewed journal articles. His research spans a broad spectrum—from investigator-initiated studies and multi-center trials to national cooperative group clinical protocols—driving innovation and improving outcomes in radiation oncology worldwide.